share_log

Morgan Stanley Upgrades MorphoSys to Overweight, Raises Price Target to $9.2

Benzinga ·  Oct 13, 2023 06:09

Morgan Stanley analyst James Quigley upgrades MorphoSys (NASDAQ:MOR) from Underweight to Overweight and raises the price target from $3.7 to $9.2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment